Annual SGA
$12.72 M
-$2.54 M-16.67%
December 31, 2023
Summary
- As of February 7, 2025, IPHA annual SGA is $12.72 million, with the most recent change of -$2.54 million (-16.67%) on December 31, 2023.
- During the last 3 years, IPHA annual SGA has fallen by -$1.77 million (-12.25%).
- IPHA annual SGA is now -66.66% below its all-time high of $38.15 million, reached on December 31, 2017.
Performance
IPHA SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
N/A
June 30, 2024
Summary
- IPHA quarterly SGA is not available.
Performance
IPHA Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM SGA
-$760.06 M
-$30.56 M-4.19%
June 30, 2024
Summary
- As of February 7, 2025, IPHA TTM SGA is -$760.06 million, with the most recent change of -$30.56 million (-4.19%) on June 30, 2024.
- IPHA TTM SGA is now -740.69% below its all-time high of -$90.41 million.
Performance
IPHA TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
IPHA Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -16.7% | - | - |
| 3 y3 years | -12.3% | - | - |
| 5 y5 years | -40.9% | - | - |
IPHA Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -32.8% | at low | -29.7% | at low | ||
| 5 y | 5-year | -32.8% | at low | -110.5% | at low | ||
| alltime | all time | -66.7% | +99.4% | -740.7% | at low |
Innate Pharma SA Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $12.72 M(-16.7%) | - | - |
| Dec 2022 | $15.26 M(-19.3%) | - | - |
| Dec 2021 | $18.92 M(+30.5%) | - | - |
| Apr 2021 | - | $49.28 M(+3.8%) | $193.79 M(-1.6%) |
| Jan 2021 | - | $47.50 M(+2.2%) | $196.85 M(-0.7%) |
| Dec 2020 | $14.49 M(-12.4%) | - | - |
| Oct 2020 | - | $46.46 M(-8.1%) | $198.23 M(-2.3%) |
| Jul 2020 | - | $50.55 M(-3.4%) | $202.94 M(-0.7%) |
| Apr 2020 | - | $52.34 M(+7.1%) | $204.39 M(+0.7%) |
| Jan 2020 | - | $48.88 M(-4.5%) | $202.87 M(-0.3%) |
| Dec 2019 | $16.55 M | - | - |
| Oct 2019 | - | $51.17 M(-1.6%) | $203.53 M(-0.1%) |
| Jul 2019 | - | $52.00 M(+2.3%) | $203.72 M(-0.3%) |
| Apr 2019 | - | $50.82 M(+2.6%) | $204.41 M(+33.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jan 2019 | - | $49.53 M(-3.6%) | $153.59 M(+47.6%) |
| Dec 2018 | $21.52 M(-43.6%) | - | - |
| Oct 2018 | - | $51.37 M(-2.5%) | $104.06 M(+97.5%) |
| Jul 2018 | - | $52.69 M | $52.69 M |
| Dec 2017 | $38.15 M(+269.5%) | - | - |
| Dec 2016 | $10.32 M(+58.3%) | - | - |
| Dec 2015 | $6.52 M(+2.3%) | - | - |
| Dec 2014 | $6.38 M(-55.0%) | - | - |
| Dec 2013 | $14.17 M(+13.2%) | - | - |
| Dec 2012 | $12.51 M(-11.4%) | - | - |
| Dec 2011 | $14.13 M(+51.0%) | - | - |
| Dec 2010 | $9.35 M(-33.3%) | - | - |
| Dec 2009 | $14.03 M(-20.0%) | - | - |
| Dec 2008 | $17.54 M | - | - |
FAQ
- What is Innate Pharma SA annual SGA?
- What is the all time high annual SGA for Innate Pharma SA?
- What is Innate Pharma SA annual SGA year-on-year change?
- What is the all time high quarterly SGA for Innate Pharma SA?
- What is Innate Pharma SA TTM SGA?
- What is the all time high TTM SGA for Innate Pharma SA?
What is Innate Pharma SA annual SGA?
The current annual SGA of IPHA is $12.72 M
What is the all time high annual SGA for Innate Pharma SA?
Innate Pharma SA all-time high annual SGA is $38.15 M
What is Innate Pharma SA annual SGA year-on-year change?
Over the past year, IPHA annual SGA has changed by -$2.54 M (-16.67%)
What is the all time high quarterly SGA for Innate Pharma SA?
Innate Pharma SA all-time high quarterly SGA is $52.69 M
What is Innate Pharma SA TTM SGA?
The current TTM SGA of IPHA is -$760.06 M
What is the all time high TTM SGA for Innate Pharma SA?
Innate Pharma SA all-time high TTM SGA is -$90.41 M